Neuren Pharmaceuticals LimitedASX: NEU

Update on trofinetide Phase 3 trial in Rett syndrome

Feb 19, 2020 at 7:02 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment